Neurology
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
To assess the efficacy and safety of the dopamine agonist cabergoline in the treatment of patients with idiopathic restless legs syndrome (CATOR study). ⋯ Single-evening cabergoline is an efficacious and well-tolerated short-term therapy for sensorimotor symptoms of restless legs syndrome and associated sleep disturbances.